Health Canada - Federal department responsible for drug approvals and health regulation in Canada
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| RISPERIDONE | sivem pharmaceuticals ulc | Marketed | Nov 9, 2023 | Marketed |
| RISPERIDONE | sivem pharmaceuticals ulc | Marketed | Nov 9, 2023 | Marketed |
| RISPERIDONE | sivem pharmaceuticals ulc | Marketed | Nov 9, 2023 | Marketed |
| RISPERIDONE | sivem pharmaceuticals ulc | Marketed | Nov 9, 2023 | Marketed |
| BIMEPRAZOL | BIMEDA-MTC ANIMAL HEALTH INC | Marketed | Nov 8, 2023 | Marketed |
| RIVAROXABAN | sivem pharmaceuticals ulc | Marketed | Nov 8, 2023 | Marketed |
| RIVAROXABAN | sivem pharmaceuticals ulc | Marketed | Nov 8, 2023 | Marketed |
| RIVAROXABAN | sivem pharmaceuticals ulc | Marketed | Nov 8, 2023 | Marketed |
| RIVAROXABAN | sivem pharmaceuticals ulc | Marketed | Nov 8, 2023 | Marketed |
| HYQVIA | takeda canada inc | Marketed | Nov 7, 2023 | Marketed |
| HYQVIA | takeda canada inc | Marketed | Nov 7, 2023 | Marketed |
| HYQVIA | takeda canada inc | Marketed | Nov 7, 2023 | Marketed |
| HYQVIA | takeda canada inc | Marketed | Nov 7, 2023 | Marketed |
| HYQVIA | takeda canada inc | Marketed | Nov 7, 2023 | Marketed |
| CROSSFIRE 256 | MATRIX ENVIRONMENTAL SOLUTIONS LTD | Marketed | Nov 6, 2023 | Marketed |
| RIVA RIVAROXABAN | laboratoire riva inc. | Marketed | Nov 6, 2023 | Marketed |
| VYVGART | ARGENX BV | Marketed | Nov 6, 2023 | Marketed |
| RIVA RIVAROXABAN | laboratoire riva inc. | Marketed | Nov 6, 2023 | Marketed |
| RIVA RIVAROXABAN | laboratoire riva inc. | Marketed | Nov 6, 2023 | Marketed |
| RIVA RIVAROXABAN | laboratoire riva inc. | Marketed | Nov 6, 2023 | Marketed |
